| Name | Title | Contact Details |
|---|
Polyplus Transfection is a San Marcos, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Southwest Foundation For Biomedical Research is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Triosyn Research Inc is a Mirabel, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Adolor Corporation is a Exton, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Oncobiologics, Inc. has changed its name to Outlook Therapeutics, Inc. Outlook Therapeutics is a clinical-stage biopharmaceutical company focused on developing its lead clinical program, ONS-5010, a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration (wet AMD). ONS-5010 is currently in its first clinical trial, which is being conducted outside of the U.S. and is designed to serve as the first of two adequate and well controlled studies for wet AMD.